Company Encyclopedia
View More
name
AUTEK
300595.SZ
Autek China Inc. engages in the research and development, production, and sale of hard contact lens products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices.
345.63 B
300595.SZMarket value -Rank by Market Cap -/-

Financial Score

06/12/2025 Update
C
Health Care SuppliesIndustry
Industry Ranking18/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE10.24%B
    • Profit Margin27.08%A
    • Gross Margin73.18%A
  • Growth ScoreC
    • Revenue YoY-1.80%D
    • Net Profit YoY-24.49%D
    • Total Assets YoY6.72%B
    • Net Assets YoY5.92%B
  • Cash ScoreC
    • Cash Flow Margin369.21%C
    • OCF YoY-1.80%D
  • Operating ScoreD
    • Turnover0.29D
  • Debt ScoreA
    • Gearing Ratio15.48%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Autek China Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025

    Autek China Inc. reported its earnings for the nine months ending September 30, 2025. The company achieved sales of CNY 1,432.79 million, slightly up from CNY 1,430.99 million the previous year. However, net income decreased to CNY 442.05 million from CNY 522.58 million year-over-year. Basic and diluted earnings per share from continuing operations both stood at CNY 0.495, down from CNY 0.5852 a year ago.

    marketscreener·
    SZ
    300595
    +1.04%
    marketscreener·
    SZ
    300595
    +1.04%

    AUTEK released its performance for the first three quarters, with a net profit attributable to the parent company of 442 million yuan, a decrease of 15.41%

    According to the Zhitong Finance APP, AUTEK released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.433 billion yuan, a year-on-year increase of 0.13%. The net profit attributable to shareholders of the listed company was 442 million yuan, a year-on-year decrease of 15.41%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 392 million yuan, a year-on-year decrease of 17.21%. The basic earnings per share were 0.495 yuan

    Zhitong·
    SZ
    300595
    +1.04%
    Zhitong·
    SZ
    300595
    +1.04%

    AUTEK: Soft hydrophilic contact lenses have obtained medical device registration certificates

    A wholly-owned subsidiary of AUTEK, Jiangsu Duozi Medical Technology Co., Ltd., has obtained a Class III medical device registration certificate for its new product "soft hydrophilic contact lenses." This product is a daily-wear soft hydrophilic contact lens with a water content of 43%, recommended for a replacement cycle of one day, sterilized by moist heat, with a shelf life of 5 years, suitable for correcting myopia in patients without contraindications. The registration certificate number is 20253162076, valid until October 20, 2030

    Zhitong·
    SZ
    300595
    +1.04%
    Zhitong·
    SZ
    300595
    +1.04%

    AUTEK has obtained a medical device registration certificate

    According to the Zhitong Finance APP, AUTEK announced that the company recently received the "Medical Device Registration Certificate" issued by the Anhui Provincial Drug Administration, and the company's "Medical Ultrasonic Nebulizer" has completed registration and obtained the Class II Medical Device Registration Certificate

    Zhitong·
    SZ
    300595
    +1.04%
    Zhitong·
    SZ
    300595
    +1.04%

    AUTEK: The company holds a cautious attitude towards the newly established optometry terminals

    AUTEK stated in an online meeting on August 25 that it expects to increase the number of controlled optical terminals by 30 by the first half of 2025, bringing the total to over 520. Due to the weakness in the high-end consumer medical market, the company is taking a cautious approach to the establishment of new optical terminals, emphasizing that implementation must have significant feasibility. At the same time, the company's investment focus has shifted to optical service institutions that already have a substantial business scale in the region and possess sustainable growth potential

    Zhitong·
    SZ
    300595
    +1.04%
    Zhitong·
    SZ
    300595
    +1.04%
    © 2025 Longbridge｜Disclaimer